| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |